JOHNSON & JOHNSON is 28.8x more valuable than INSMED Inc by market capitalization ($574.10 B vs $19.92 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | INSM | JNJ |
|---|---|---|
| Market cap | $19.92 B | $574.10 B |
| US-listed rank | #620 | #20 |
| Revenue (latest FY) | $606.42M | $94.19B |
| Net income (latest FY) | -$1.28B | $26.80B |
| Net margin | -210.5% | 28.5% |
| P/E (trailing FY) | - | 21.4 |
| SEC filings | 1,776 | 984 |
JOHNSON & JOHNSON is 28.8x more valuable than INSMED Inc by market capitalization ($574.10 B vs $19.92 B).
In their latest fiscal years, INSMED Inc reported $606.42M in revenue while JOHNSON & JOHNSON reported $94.19B.
Full pages: INSMED Inc and JOHNSON & JOHNSON, or browse the full rankings.